NIH-funded research NIH-funded research

Building collaborations for cancer research and drug development

Official title: Capacity Development Core

Funded at University of California Riverside · NIH-10933468 · Data updated 2026-11-12

This study is all about helping new cancer researchers at City of Hope and UC Riverside work together, get guidance from experienced mentors, and find funding to develop new cancer treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Riverside
NIH-funded
Lab location1 site (Riverside, United States)
Project startSeptember 22, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$186,283
NIH project number5U54CA285114-02
Project IDNIH-10933468 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are early-stage investigators in cancer research at the University of California, Riverside.

Less likely to help

Patients who are not involved in cancer research or are not early-stage investigators may not receive direct benefits from this research.

What this research studies

This research focuses on enhancing collaboration between the City of Hope Comprehensive Cancer Center and the University of California, Riverside, particularly for early-stage investigators. It aims to provide mentorship and resources to help these investigators develop their capacity for drug development and secure independent NIH funding. The program includes funding for pilot projects that will be crafted by early-stage investigators under the guidance of experienced mentors. By fostering these partnerships, the initiative seeks to improve research outcomes and innovation in cancer treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved drug development processes and better funding opportunities for early-stage cancer researchers.

How similar studies have gone: Previous research has shown that mentorship and collaboration can significantly enhance the success rates of early-stage investigators in securing funding and advancing their projects.

Where this research is happening

  • University of California Riverside
    Riverside, United States
    Active

Researchers

  • Principal investigator: Martinez, Ernest — University of California Riverside
  • Study coordinator: Martinez, Ernest

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.